American Journal of Kidney Diseases

Slides:



Advertisements
Similar presentations
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Advertisements

USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
Volume 59, Issue 2, Pages (February 2001)
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease    American Journal of Kidney Diseases 
Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD  Akshay S. Desai, MD, MPH,
Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index  Suma Vupputuri, PhD, Caroline.
Body Mass Index and All-cause Mortality in Chronic Kidney Disease: A Dose–response Meta-analysis of Observational Studies  Mehran Rahimlu, MSc, Sakineh.
Evaluation of Kidney Donors: Core Curriculum 2018
In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’  Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.
End-stage renal disease in developing countries
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Development of Reduced Kidney Function in Rheumatoid Arthritis
Independent Community House Hemodialysis as a Novel Dialysis Setting: An Observational Cohort Study  Mark R. Marshall, BHB, MBChB, FRACP, MPH (Hons),
Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes  Eduardo Lacson, MD, MPH, Weiling Wang,
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
A Decade After the KDOQI CKD Guidelines
Update on Diabetic Nephropathy: Core Curriculum 2018
The US Renal Data System “Pie Chart of Death”
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP) 
Solute-Solver: A Web-Based Tool for Modeling Urea Kinetics for a Broad Range of Hemodialysis Schedules in Multiple Patients  John T. Daugirdas, MD, Thomas.
Volume 64, Issue 3, Pages (September 2003)
Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial  Hao Yan, MD, Wei Fang, MD,
Impact of Electronic Acute Kidney Injury (AKI) Alerts With Automated Nephrologist Consultation on Detection and Severity of AKI: A Quality Improvement.
Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)  Richard.
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V
Masaru Horio  American Journal of Kidney Diseases 
Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study  Martin J. Landray, PhD,
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Meeting the challenges of the new K/DOQI guidelines
Guidelines for the Older Adult With CKD
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
On Statin Treatment to Prevent Sepsis in Dialysis Patients
American Journal of Kidney Diseases
Polyunsaturated Fatty Acids and Kidney Disease
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
Body size and outcomes on peritoneal dialysis in the United States
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Update on Diabetic Nephropathy: Core Curriculum 2018
Christina L. Klein, MD, Daniel C. Brennan, MD, FACP 
American Journal of Kidney Diseases
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD 
Drug Dose Adjustments in Patients With Renal Impairment
Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D
Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States  George A. Kaysen, MD, PhD, Kirsten.
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
Volume 64, Issue 2, Pages (August 2003)
Volume 76, Issue 6, Pages (September 2009)
Was It the Nephrologists or the Fluid?
The Use of Vaccines in Adult Patients With Renal Disease
In the Literature: Cognitive Impairment in Hemodialysis Patients
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Renal replacement therapy in Latin America
American Journal of Kidney Diseases
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Volume 59, Issue 2, Pages (February 2001)
Volume 61, Issue 2, Pages (February 2002)
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes  Diana Mina, Kirsten L. Johansen, Charles E. McCulloch,
Update on Cystatin C: Incorporation Into Clinical Practice
Presentation transcript:

American Journal of Kidney Diseases Transfers to Hemodialysis Among US Patients Initiating Renal Replacement Therapy With Peritoneal Dialysis  Rita L. McGill, Daniel E. Weiner, Robin Ruthazer, Dana C. Miskulin, Klemens B. Meyer, Eduardo Lacson  American Journal of Kidney Diseases  DOI: 10.1053/j.ajkd.2019.05.014 Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Flow chart of patients included in the study. Abbreviations: BMI, body mass index; GFR, glomerular filtration rate; HD, hemodialysis; PD, peritoneal dialysis; USRDS, US Renal Data System. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.05.014) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Hemodialysis transfer, kidney transplantation, and death over time for all incident peritoneal dialysis patients. The prevalence of each outcome is shown as the vertical height of the appropriate area at each time point on the horizontal axis. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.05.014) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Interactions of the subdistribution hazard ratios for hemodialysis transfer with patient age. The dashed line shows the subdistribution hazard ratios for employment versus unemployment, which increases with increasing age. The solid and dotted lines show that subdistribution hazard ratios for primary diabetic nephropathy or hypertensive nephropathy versus other causes of kidney failure decrease with increasing age. Abbreviations: DM, diabetes meelitus; HTN, hypertension. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.05.014) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Competing-risks nomogram. To calculate points for an individual patient, the patient’s value for each characteristic should be traced upward to the Points axis. For example, body mass index (BMI) of 40kg/m2 would receive 50 points. The last 3 axes (AGE_if_DM [diabetes mellitus], AGE_if_HTN [hypertension], and AGE_if_employed) represent interaction variables. For patients who meet the conditions specified (diabetic nephropathy [DMneph], hypertensive nephropathy [HTNneph], employment [EMP]), points are assessed based on age. For patients who do not meet these conditions (eg, nondiabetic, not hypertensive nephropathy, unemployed), points are assigned based on the zero point of the axis. Total score is the sum of points from each patient axis, which is used to draw a vertical line in the lower pane of the nomogram. Predicted cumulative incidences of hemodialysis (HD) transfer at 12, 24, 36, and 48 months are read from where this vertical line intersects the axes in the lower pane. Abbreviation: GFR, glomerular filtration rate. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.05.014) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions

Figure 5 The dotted, dashed, solid black, and grey lines represent the cumulative incidences of peritoneal dialysis (PD) to hemodialysis (HD) transfer over time among the 4 risk quartiles assigned in the subdistribution hazards model. Quartile 1 (Q1) has the lowest risk for HD transfer. American Journal of Kidney Diseases DOI: (10.1053/j.ajkd.2019.05.014) Copyright © 2019 National Kidney Foundation, Inc. Terms and Conditions